CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


La Jolla Pharmaceutical Co  (LJPC)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 

La Jolla Pharmaceutical Co's Quick Ratio

LJPC's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:                        

LJPC Quick Ratio (Jun 30 2017)
II. Quarter
(Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
Y / Y Current Liabilities Change 60.2 % 9.71 % 102.45 % 66.69 % 103.43 %
Y / Y Cash & cash equivalent Change 40.53 % 43.61 % -48.03 % -37.04 % 178.98 %
Quick Ratio MRQ 17.09 28.62 6.74 11.75 19.48
Overall Ranking # 155 # 94 # 0 # 0 # 0
Seq. Current Liabilities Change 45.8 % -41.86 % 34.85 % 40.15 % -0.15 %
Seq. Cash & cash equivalent Change -12.97 % 147.06 % -22.71 % -15.44 % -11.07 %



Quick Ratio second quarter 2017 Comment
Due to increase in Current Liabilities in the second quarter 2017, Quick Ratio fell to 17.09 below La Jolla Pharmaceutical Co average.

Within Biotechnology & Drugs industry 13 other companies have achieved higher Quick Ratio than La Jolla Pharmaceutical Co in second quarter 2017. While Quick Ratio total ranking has deteriorated compare to previous quarter from 98 to 171.

Explain Quick Ratio?
What are LJPC Segments?
See Quick Ratio LJPC on the trailing twelve month basis
Quick Ratio second quarter 2017 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 14
Healthcare Sector # 37
Overall Market # 171


Quick Ratio Statistics
High Average Low
33.52 15.48 0.32
(Sep 30 2014)   (Dec 31 2011)


You need to upgrade your Flash Player


Financial Statements
La Jolla Pharmaceutical Co's Current Liabilities $ 8 Millions Visit LJPC's Balance sheet
La Jolla Pharmaceutical Co's Cash & cash equivalent $ 141 Millions Visit LJPC's Balance sheet
Source of LJPC's Sales Visit LJPC's Sales by Geography




Companies with similar Quick Ratio in the quarter endingJun 30 2017, within Biotechnology & Drugs Industry Quick RatioJun 30 2017 MRQ Cash & cash equivalentJun 30 2017 MRQ Current Liabilities
Protokinetix, Inc.  44.13 $ 0.238  Millions$ 0.005  Millions
Regenxbio Inc.  41.05 $ 162.083  Millions$ 3.948  Millions
Enzon Pharmaceuticals, Inc.  23.01 $ 11.206  Millions$ 0.487  Millions
Aerie Pharmaceuticals Inc  22.30 $ 307.919  Millions$ 13.810  Millions
Neurocrine Biosciences Inc  18.94 $ 525.020  Millions$ 27.721  Millions
Atara Biotherapeutics, Inc.  18.91 $ 217.090  Millions$ 11.481  Millions
Gtx Inc  18.83 $ 11.356  Millions$ 0.603  Millions
Fennec Pharmaceuticals Inc.  17.64 $ 10.232  Millions$ 0.580  Millions
Anavex Life Sciences Corp.  17.27 $ 24.793  Millions$ 1.436  Millions
Crispr Therapeutics Ag  17.22 $ 272.264  Millions$ 15.814  Millions
La Jolla Pharmaceutical Co  17.09 $ 141.317  Millions$ 8.271  Millions
Microbot Medical Inc.  17.03 $ 13.078  Millions$ 0.768  Millions
Organovo Holdings, Inc.  14.91 $ 54.974  Millions$ 3.688  Millions
Bluebird Bio, Inc.  14.07 $ 1,095.434  Millions$ 77.838  Millions
Obalon Therapeutics Inc  13.13 $ 60.725  Millions$ 4.625  Millions
Asterias Biotherapeutics, Inc.  12.39 $ 25.016  Millions$ 2.019  Millions
Adaptimmune Therapeutics Plc  11.97 $ 202.021  Millions$ 16.881  Millions
Voyager Therapeutics, Inc.  11.94 $ 141.323  Millions$ 11.836  Millions
Syndax Pharmaceuticals Inc  11.30 $ 130.056  Millions$ 11.505  Millions
Fulgent Genetics, Inc.  10.61 $ 28.873  Millions$ 2.722  Millions
Idera Pharmaceuticals, Inc.  10.51 $ 77.235  Millions$ 7.351  Millions
Lixte Biotechnology Holdings, Inc.  10.11 $ 2.032  Millions$ 0.201  Millions
Acceleron Pharma Inc  10.04 $ 143.553  Millions$ 14.299  Millions
Audentes Therapeutics, Inc.  9.82 $ 145.828  Millions$ 14.855  Millions
Brainstorm Cell Therapeutics Inc.  9.45 $ 6.717  Millions$ 0.711  Millions
Edge Therapeutics, Inc.  9.38 $ 108.715  Millions$ 11.591  Millions
Intellia Therapeutics, Inc.  9.14 $ 241.047  Millions$ 26.371  Millions
Compugen Ltd  9.10 $ 46.111  Millions$ 5.067  Millions
Cadus Corp  8.90 $ 4.366  Millions$ 0.491  Millions
Kite Pharma, Inc.  8.82 $ 781.111  Millions$ 88.564  Millions
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

LOW's Profile

Stock Price

LOW's Financials

LOW's Expectations

Business Description

Fundamentals

Charts & Quotes

LOW's News

Suppliers

LOW's Competitors

Customers & Markets

Economic Indicators

LOW's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com